ADMdx has been awarded a Small Business Innovation Research grant from the National Institutes of Aging, focused on the prediction of tau burden in the brain using MRI scans and machine learning. PET tracers for tau have made it possible to measure abnormal tau accumulation, one of the hallmark pathologies of Alzheimer’s disease. Using tau PET scans and structural MRI scans from the same patients, ADMdx will explore the ability to use structural MRI, a broadly available imaging technology, to predict the presence and distribution of abnormal tau.
